Inflammation, anti-inflammatory agents, and the role of colchicine in carotid artery stenosis.

Cardiovascular disease is a major cause of morbidity and mortality worldwide. In the last few years, the role of inflammation and inflammatory modulatory medications is investigated for the optimal treatment of coronary artery disease. It can be hypothesized that since inflammation is also involved in carotid artery stenosis development and progression, the same class of medication could be useful. Our objective with this review is to present the available evidence, published studies and promising ongoing trials on the role of anti-inflammatory medications - with a special emphasis on the most commonly used drug of this class: colchicine - in patients with carotid artery stenosis.

[1]  F. Colbourne,et al.  Colchicine pre-treatment and post-treatment does not worsen bleeding or functional outcome after collagenase-induced intracerebral hemorrhage , 2022, PloS one.

[2]  Ruihai Xiao,et al.  Colchicine linked with risk reduction for myocardial infarction in gout patients: systematic review and meta-analysis , 2022, Zeitschrift für Rheumatologie.

[3]  B. Chan,et al.  The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis , 2022, Journal of Thrombosis and Thrombolysis.

[4]  Hailang Liu,et al.  Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials. , 2022, Heart, lung & circulation.

[5]  A. Triantafyllou,et al.  Assessment of vascular damage in children and young adults with Familial Mediterranean Fever , 2021, Rheumatology International.

[6]  Ana Catarina Fonseca,et al.  Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) – study protocol for a randomised controlled trial , 2021, European stroke journal.

[7]  I. van Herzeele,et al.  European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis , 2021, European stroke journal.

[8]  D. Kokkinidis,et al.  Transcervical Carotid Artery Revascularization: a Systematic Review and Meta-analysis of Outcomes. , 2021, Journal of vascular surgery.

[9]  M. Casula,et al.  Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients. , 2021, European journal of preventive cardiology.

[10]  E. Yilmaz,et al.  The Efficacy of Colchicine on Carotid Intima-Media Thickness: A Prospective Comparative Study. , 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[11]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[12]  V. Aboyans,et al.  Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review , 2020, European heart journal supplements : journal of the European Society of Cardiology.

[13]  D. Kokkinidis,et al.  Presence of Contralateral Carotid Occlusion Is Associated With Increased Periprocedural Stroke Risk Following CEA but Not CAS: A Meta-analysis and Meta-regression Analysis of 43 Studies and 96,658 Patients , 2020, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[14]  P. K. Sharma Atherosclerosis. , 2020, The Journal of the Association of Physicians of India.

[15]  Aiping Zeng,et al.  Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: A meta-analysis. , 2019, International immunopharmacology.

[16]  S. Stabouli,et al.  Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment , 2019, Clinical Rheumatology.

[17]  Qingjuan He,et al.  The Effect of Puerarin on Carotid Intima-media Thickness in Patients With Active Rheumatoid Arthritis: ARandomized Controlled Trial. , 2018, Clinical therapeutics.

[18]  P. Jabbour,et al.  Preoperative Use of Statins in Carotid Artery Stenting: A Systematic Review and Meta-analysis , 2018, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[19]  J. H. Rudd,et al.  18F-FDG Uptake on PET/CT in Symptomatic versus Asymptomatic Carotid Disease: a Meta-Analysis , 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[20]  D. Celermajer,et al.  The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. , 2017, Atherosclerosis.

[21]  J. Beckman,et al.  Medical Management of Asymptomatic Carotid Artery Stenosis. , 2017, Progress in cardiovascular diseases.

[22]  M. Nurmohamed,et al.  Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders , 2016, Heart.

[23]  O. Franco,et al.  Carotid stiffness is associated with incident stroke: a systematic review and individual participant data meta-analysis. , 2015, Journal of the American College of Cardiology.

[24]  P. Camici,et al.  Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis , 2015, Mediators of inflammation.

[25]  E. Matteson,et al.  The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease , 2015, Annals of the rheumatic diseases.

[26]  F. Moll,et al.  Relationship of MMP-14 and TIMP-3 Expression with Macrophage Activation and Human Atherosclerotic Plaque Vulnerability , 2014, Mediators of inflammation.

[27]  W. Taki,et al.  Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability , 2014, PloS one.

[28]  P. Libby,et al.  Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. , 2013, American heart journal.

[29]  D. Ziaja,et al.  Inflammatory markers in patients with internal carotid artery stenosis , 2013, Archives of medical science : AMS.

[30]  G. Nijpels,et al.  Different Type of Carotid Arterial Wall Remodeling in Rheumatoid Arthritis Compared with Healthy Subjects: A Case-Control Study , 2012, The Journal of Rheumatology.

[31]  E. Vicaut,et al.  Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011) , 2012, Cerebrovascular Diseases.

[32]  Oliver Gaemperli,et al.  Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. , 2012, European heart journal.

[33]  R. Agha,et al.  Neutrophil-Lymphocyte Ratio Predicts Medium-Term Survival Following Elective Major Vascular Surgery: A Cross-Sectional Study , 2011, Vascular and endovascular surgery.

[34]  Paul M Ridker,et al.  Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.

[35]  B. Bhattacharyya,et al.  Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin , 2008, Medicinal research reviews.

[36]  P. Rothwell,et al.  Long-term risk of stroke and other vascular events in patients with asymptomatic carotid artery stenosis. , 2002, Archives of neurology.